Researchers from Department of Pharmacy to boost Danish export
Pharmaceuticals and food products represent two of the largest export products of Denmark. It is essential for patient safety that the quality of these products is not compromised during transportation. Especially pharmaceutical products must be composed of the right type of particles, which must not be affected by, for example, high humidity and high temperatures. In a project co-financed by the foundation Innovationsfonden – Denmark, researchers from Department of Pharmacy will now help to provide knowledge and solutions intended to ensure a safe and effective production of pharmaceuticals for the benefit of patients, companies and the knowledge society.
For the patients to benefit from their medicine, it is crucial that it is safe and is not damaged by, for example, heat and moisture. The medicine must therefore be made of stable materials capable of withstanding the physical challenges to which it is exposed during transportation. Now, a new large project – High-Quality Dry Products With Superior Functionality and Stability, also called Q-Dry – will conduct research into how powder materials and dry ingredients can be produced in such a manner that the substances can be manufactured in an optimal way and they withstand long-distance transportation.
"Pharmaceuticals consist of particles in a variety of shapes and sizes. Some pharmaceuticals may be negatively affected by physical factors such as high temperatures and moisture. The new project allows us to conduct research into how we can produce safe and stable pharmaceuticals capable of withstanding being exported over large distances and still have the desired function", says Professor Jukka Rantanen, Department of Pharmacy, University of Copenhagen.
Preparing pharmaceutical production in Denmark for the future Pharmaceuticals represent one of Denmark's largest export products, totalling DKK 80 billion in 2015. In the new project, the researchers involved will also help to ensure that the actual production of pharmaceuticals will take place on Danish soil.
"The project is intended to provide us with a better understanding of powder, its material characteristics and its behaviour. When we have this knowledge, we can make sure that our products rank among the best in the world. Doing research and developing new compounds is one thing, but the new knowledge about powder properties will secure us a place among the best manufacturers of pharmaceuticals. This will also ensure that the production of pharmaceuticals will remain in Denmark, and, in this way, the project will also benefit our students in terms of securing future jobs and retention of talents", says Jukka Rantanen.
In addition to the Department of Pharmacy, seven other partners are also involved in the project, which will help the industry to address the challenges related to exporting dry products to new growth markets with high humidity and temperatures.
Partners: Teknologisk Institut, Institut for Fødevarevidenskab (UCPH), Fertin Pharma A/S, KMC (Kartoffelmelcentralen), Novozymes A/S, SiccaDania A/S, DC Ingredients, Haldor Topsøe.
Q-Dry - High Quality Dry Products With Superior Functionality and Stability
Innovation Fund Denmark, Investment
DKK 17.6 million
Project Budget, total
DKK 28.6 million